CDK4 and ovarian carcinoma: Consistent with the observations from DepMap, KURAMOCHI, an ovarian cancer cell line, and MB157, a TNBC cell line, both from cluster 3, displayed a robust growth arrest following RNAi-mediated CDK2 depletion, while CDK4 depletion showed no effect (Fig. 1D).